Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 5769 (117th)

Access to Breast Cancer Diagnosis Act of 2021

referredUnited States· United States Congress· EN

Introduced

28 October 2021

Last action

29 October 2021 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Dingell, Debbie [D-MI-6], Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Cole, Tom [R-OK-4], Colin Allred, Rep. McBath, Lucy [D-GA-6], Rep. Doggett, Lloyd [D-TX-37], Rep. Pressley, Ayanna [D-MA-7], Rep. Lucas, Frank D. [R-OK-3], Sen. Kim, Andy [D-NJ], Rep. Luria, Elaine G. [D-VA-2], Rep. Soto, Darren [D-FL-9], Rep. Wild, Susan [D-PA-7], Rep. Van Duyne, Beth [R-TX-24], Rep. Neguse, Joe [D-CO-2], Rep. Cooper, Jim [D-TN-5], Rep. Barragán, Nanette Diaz [D-CA-44], Sen. Blunt Rochester, Lisa [D-DE], Rep. Fletcher, Lizzie [D-TX-7], Rep. Morelle, Joseph D. [D-NY-25], Rep. Hudson, Richard [R-NC-8], Rep. Kilmer, Derek [D-WA-6], Sen. Mullin, Markwayne [R-OK], Rep. Butterfield, G. K. [D-NC-1], Rep. Aguilar, Pete [D-CA-33], Rep. Kim, Young [R-CA-40], Rep. Houlahan, Chrissy [D-PA-6], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Trone, David J. [D-MD-6], Rep. Jones, Mondaire [D-NY-17], Rep. Cohen, Steve [D-TN-9], Marie Newman, Rep. Malinowski, Tom [D-NJ-7], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Craig, Angie [D-MN-2], Rep. Connolly, Gerald E. [D-VA-11], Rep. Kirkpatrick, Ann [D-AZ-2], Rep. Titus, Dina [D-NV-1], Rep. Raskin, Jamie [D-MD-8], Rep. Moore, Gwen [D-WI-4], Rep. Mann, Tracey [R-KS-1], Rep. Kelly, Robin L. [D-IL-2], Rep. Dean, Madeleine [D-PA-4], Rep. Meng, Grace [D-NY-6], Rep. Burgess, Michael C. [R-TX-26], Rep. Peters, Scott H. [D-CA-50], Rep. Bost, Mike [R-IL-12], Rep. Auchincloss, Jake [D-MA-4]

Subjects

Healthcare

Source updated

3 January 2025

Healthcare

Summary

Access to Breast Cancer Diagnosis Act of 20 21 This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 October 2021

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 28 October 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 28 October 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 29 October 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 28 October 2021

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 28 October 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 28 October 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 50 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.